PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
36.29%
Revenue growth similar to OGI.TO's 37.32%. Walter Schloss would see if both companies share industry tailwinds.
57.21%
Gross profit growth under 50% of OGI.TO's 303.17%. Michael Burry would be concerned about a severe competitive disadvantage.
-181.24%
Negative EBIT growth while OGI.TO is at 253.61%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-181.24%
Negative operating income growth while OGI.TO is at 253.61%. Joel Greenblatt would press for urgent turnaround measures.
-57.90%
Negative net income growth while OGI.TO stands at 176.76%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-53.60%
Negative EPS growth while OGI.TO is at 165.81%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-60.74%
Negative diluted EPS growth while OGI.TO is at 159.81%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.09%
Share reduction more than 1.5x OGI.TO's 18.63%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.10%
Diluted share reduction more than 1.5x OGI.TO's 25.95%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
210.71%
OCF growth under 50% of OGI.TO's 2775.43%. Michael Burry might suspect questionable revenue recognition or rising costs.
-9.01%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-52.57%
Negative 10Y OCF/share CAGR while OGI.TO stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
4994.38%
5Y OCF/share CAGR above 1.5x OGI.TO's 540.14%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
1997.53%
3Y OCF/share CAGR above 1.5x OGI.TO's 856.39%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
733.01%
10Y net income/share CAGR of 733.01% while OGI.TO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
838.92%
5Y net income/share CAGR above 1.5x OGI.TO's 225.07%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
2455.14%
3Y net income/share CAGR above 1.5x OGI.TO's 173.31%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
1295.21%
Equity/share CAGR of 1295.21% while OGI.TO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
2660.69%
5Y equity/share CAGR at 50-75% of OGI.TO's 4019.75%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
6638.11%
3Y equity/share CAGR above 1.5x OGI.TO's 815.51%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-52.39%
Firm’s AR is declining while OGI.TO shows 39.66%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
43.08%
Inventory shrinking or stable vs. OGI.TO's 86.30%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
30.23%
Asset growth well under 50% of OGI.TO's 178.21%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
30.94%
50-75% of OGI.TO's 56.60%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-3.01%
We’re deleveraging while OGI.TO stands at 2726.47%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-13.16%
Our R&D shrinks while OGI.TO invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
10.77%
SG&A declining or stable vs. OGI.TO's 41.51%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.